Quest Diagnostics Inc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
Quest Diagnostics Inc (DGX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) of -$1.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2015-02-24.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss · last filed 2015-02-24
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2013-12-31 was -$1.45M.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2013-09-30 was -$51.00K.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2013-06-30 was $595.00K.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2013-03-31 was -$94.00K.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2013 was -$1.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$1.50M derived: sum of 2 quarters · filed 2015-02-24 | -$906.00K derived: sum of 3 quarters · filed 2015-02-24 | -$1.00M 10-K · filed 2015-02-24 |
| 2013-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $544.00K derived: sum of 2 quarters · filed 2013-10-24 | $450.00K 10-Q · filed 2013-10-24 | |
| 2013-06-30 | $595.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $501.00K 10-Q · filed 2013-07-25 | ||
| 2013-03-31 | -$94.00K 10-Q · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |